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ABSTRACT We have investigated the linkage between
CD4/CD8 phenotype and programing for specific responses in
primary T-cell populations. In situ hybridization has been used
to determine the frequency of cells competent to express the
interleukin 2 (IL-2) gene after short-term stimulation with
various polyclonal activators. The effects of the T-cell receptor
ligands Con A and anti-CD3 monoclonal antibody were com-
pared with those of a calcium ionophore that bypasses mem-
brane receptors altogether. Induction with a calcium ionophore
and phorbol ester revealed that potential IL-2 producers not
only constitute >85% of the cells with a CD4' "helper/
inducer" phenotype but also constitute over half of the cells
with a CD8' "killer/suppressor" phenotype. There is no
defect in the ability of these CD8' cells to accumulate IL-2
transcripts under these conditions. By contrast, in response to
phorbol ester and either Con A or anti-CD3, the CD8' cells
show an abortive IL-2 production response with rapid disap-
pearance of IL-2 mRNA. This results in substantially lower
yields of IL-2 per cell than is made by CD4+ cells in response
to the same stimuli. The extent to which these populations
appear to have diverged in function thus depends on the
stimulus used to trigger the response. The results suggest that
differences in signal transduction or posttranscriptional regu-
latory mechanisms, rather than effector gene inducibility per
se, may initially underlie the commitment of CD4+ and CD8+
cells to distinct functional roles.
Mature T cells are functionally specialized in their responses
to recognition of antigen. In general, T-cell lines that express
the CD4 cell-surface glycoprotein are "helper" or "am-
plifier" cells that respond to the recognition of antigen by
secreting lymphokines, often including the major T-cell
growth factor interleukin 2 (IL-2) (1, 2). Cells that express
CD8 include most killer T cells and show little helper activity
(3-6). This suggests that the constitutive CD4/CD8 pheno-
types of T cells are correlated with the inducibility of
different, limited sets of functional response genes. Although
the correlation is frequently observed in memory T cells and
T-cell lines, it is not known how it is established during T-cell
differentiation. When fresh CD8+ cells are activated and
cloned, '10% of the clones respond to stimulation by
expression of IL-2 (5, 6). This would suggest an intrinsic
difference between CD8 + cells and CD4+ cells in programing
for gene expression. However, in a variety of other studies,
CD8 + cells appear to make IL-2 as well as CD4+ cells (7-11).
In the work reported here, we used in situ hybridization and
quantitative probe protection analyses to measure the accu-
mulation of IL-2 mRNA in individual splenic T cells respond-
ing for the first time to different stimuli. We demonstrate that
the majority of CD4+ and :50% of CD8+ splenocytes are
competent to accumulate similarly high levels of IL-2 mRNA
when treated with calcium ionophore and phorbol ester.
However, the two cell types differ markedly in their kinetics
of message accumulation when stimulated by means of the
T-cell receptor with concanavalin A (Con A) or an anti-CD3
monoclonal antibody (mAb). The results suggest that primary
CD4+ and CD8+ cells differ not so much in their intrinsic
abilities to initiate IL-2 transcription but by a mechanism that
limits IL-2 message accumulation in the CD8 + cells following
stimulation by means of the T-cell receptor.
MATERIALS AND METHODS
Animals. C57BL/6 or C57BL/6-Tlaa mice were bred in our
facilities and used at 6-8 weeks of age.
Cell Preparation and Culture. Cell suspensions were pre-
pared from spleen, and CD4- and CD8- populations were
isolated as described (12). Cultures were incubated with or
without 0.1 /LM A23187 (Sigma) and 17 nM phorbol 12-
myristate 13-acetate (PMA). Where indicated, Con A (Phar-
macia) at 6 jug/ml was used to replace A23187. The mAb
against murine CD3, clone 145-2C11 (13), was kindly pro-
vided by Jeffrey Bluestone (University of Chicago, Chicago)
via Linda Sherman (Research Institute of Scripps Clinic, La
Jolla, CA) and was added to the cells as a 1:10 dilution of
hybridoma supernatant. Note that our culture medium con-
tains 10%o fetal bovine serum and that under these conditions
we (12) and others (14) find IL-2 RNA expression to be
restricted to T cells. The amounts of IL-2 mRNA accumu-
lated per cell in these experiments are higher than we
previously reported, due, at least in part, to the use of a
different lot offetal calf serum, which supported higher levels
of IL-2 production by all T-cell populations tested (data not
shown). Enriched T-cell populations were obtained by two
rounds of panning using affinity-purified goat anti-mouse IgG
(Boehringer Mannheim) as described (15). In our hands,
nylon wool purification resulted in less B-cell contamination
but with significant and biased losses of T cells (data not
shown).
In Situ Hybridization. Fixed splenocytes were hybridized
with the "antisense" IL-2 probe as described (12). Grain
counts were obtained from at least 500 cells per slide. The
number of cells above background with only one grain was
extremely variable between experiments and has not been
included in the "positive" cell calculation. To analyze the
distribution of IL-2 RNA in responding cells, grain counts
from 21-month exposures were used. Under these condi-
tions, most uninduced cells still show no grains (12) and cells
that fail to respond to induction account for most of the
Abbreviations: IL-2, interleukin 2; mAb, monoclonal antibody;
PMA, phorbol 12-myristate 13-acetate; nt, nucleotide.
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zero-grain cells in an induced population (n?). The observed
percentage of cells in each grain count category in the
induced population, ni, is the percentage of "true" respond-
ing cells, ni(corr), with specific hybridization above back-
ground, plus the percentage of residual nonresponding cells,
with all grains due to background. Nonresponding cells are
assumed to show the same grain distribution as uninduced
cells (n, percent in the corresponding grain count category).
Overall, they should constitute a fraction of the induced
population, which, at most, is given by the ratio of the
percentages of zero-grain cells in the induced and uninduced
populations (n /n'). Thus, for each grain count category,
ni(corr) = ni - nu(n /n'). Distributions of ni(corr) are plotted
in Fig. 2. For the percentage of positive cells given in Table
1 (column D), the sum ofall ni(corr) for grain count categories
-2 was subjected to a further slight correction for potential
nonspecific sticking of the probe to the induced cells, by
subtracting the sum of ni(corr) obtained after hybridization
with a "sense" strand probe. The sense strand probe gave a
higher background than the antisense probe (although <10%o
cells with s2 grains) but showed little difference between
induced and uninduced samples. We have previously re-
ported the in situ hybridization technique to detect levels as
low as 10 molecules per cell in our hands (12).
Ribonuclease Probe Protection. Probe protection measure-
ments of IL-2 RNA have been described in detail elsewhere
(12). For quantitation, the 400-nucleotide (nt) HindIII-Acc I
probe for the 3' halfofthe IL-2 mRNA was used as described.
The integrity of the RNA was confirmed by electrophoresis
in a 50% urea/5% polyacrylamide gel. The average number
of molecules per cell was determined by liquid scintillation
spectrometry of protected probe retained on DE81 paper by
the following equation: pg of RNA (i.e., pg of probe pro-
tected) x (1 pmol/1.2 x 105 pg) (i.e., molecular weight of
probe = 400 nt x 300 pg/pmol of base) x (1/cell equiva-
lents) x (1 pmol/10-12 mol) x (6.03 x 1023 molecules per
mol). The sensitivity of this technique is <0.1 copy per cell
in our hands (12), and no IL-2 mRNA is ever detected in
uninduced samples. To map the 5' end of the message as
shown in Fig. 2, a 5' probe was derived from a genomic
3.0-kilobase (kb) EcoRI-HincII fragment from the 5' end of
the IL-2 gene. This was cloned into pGEM-2, cleaved with
Acc I, and transcribed to give the 220-nt antisense cRNA
probe shown in Fig. 2. Riboprobe control template size
markers (Promega Biotec, Madison, WI) were used to de-
termine fragment sizes after electrophoresis. To determine
the poly(A) sites used, the 0.8-kb genomic EcoRI fragment
including the fourth exon ofthe IL-2 gene (16) was subcloned
into pSP65 (T. J. Novak and E.V.R., unpublished results),
digested with Rsa I, and transcribed with SP6 polymerase.
The resulting 456-nt antisense transcript was used as a 3'
probe (data not shown).
RESULTS
We previously demonstrated that mature splenic T cells
accumulate large amounts of IL-2 mRNA when stimulated
for 24 hr in the presence ofthe calcium ionophore A23187 and
PMA (12). The induction ofIL-2 RNA expression in response
to these stimuli is not influenced by the presence ofaccessory
cells and is independent of antigenic stimulation (12, 17).
Production of IL-2 mRNA is decreased by >95% when all
CD4 + and CD8 + T cells are eliminated from the splenocyte
population (12). Therefore, even with stimuli that do not
require a functional T-cell receptor, IL-2 gene inducibility is
a T-cell-specific response under these conditions. As shown
in column D of Table 1, after 24 hr of treatment with A23187
and PMA, an average of20% of surviving spleen cells contain
cytoplasmic IL-2 mRNA detectable by in situ hybridization
analysis. The population of T cells in these splenocyte
samples was initially 25-30o and usually declined slightly
during culture, suggesting that the large majority of surviving
T cells in unseparated splenic cell preparations can activate
the IL-2 gene under these stimulation conditions. This
interpretation was supported by two additional experiments
analyzing responses of enriched splenic T cells. A population
with 47% Thy-1+ cells (27% CD4+, 16% CD8 ) at the start
of culture yielded 37% with IL-2 RNA and a population with
78% Thy-1+ cells (42% CD4+, 27% CD8+) responded to
stimulation by IL-2 RNA expression in 47%. Quantitative
RNase probe protection analysis demonstrated that splenic
IL-2-producing cells accumulate, on average, about 650 IL-2
transcripts per positive cell.
To determine whether both CD4 + and CD8 + cells partic-
ipated in this response, we used mAbs against CD8 and CD4
to mediate complement elimination of mature splenic T cells
bearing these cell-surface markers. Over 90% of the suscep-
tible population was eliminated when cells were subjected to
two rounds ofelimination with the appropriate antibody. This
treatment routinely allows recovery of =85% of the expected
number of total spleen cells in our hands. Additionally, after
correcting for viability and total cell recovery, we calculate
that >80%o of the input spleen cells scoring as IL-2 producers
could be recovered in one or the other eliminated population.
Table 1. IL-2 mRNA accumulation by splenic T cells
A B C D E F
Viability % T cells in % T cells % positive cells Average no. of IL-2 Average no. of IL-2 G
after culture, initial after for IL-2 RNA molecules per RNA molecules per IL-2,
Spleen % input sample* culturet mRNAt viable cell§ positive cell. units/mll
Total 54 ± 4 26 ± 2 20-23 20 ± 4 (3)** 133 ± 33 (5) 665 830
CD8- 61 + 3 22 ± 0.5 13-15 12.6 ± 2 (3) 100 ± 28 794 670
CD4- 61 ± 1 10.5 ± 0.5 10-13 6.8 ± 0.7 33 ± 3 485 290
All values are the average of two experiments with 24-hr stimulations by A23187 and PMA, except where noted in parentheses. Standard
deviations are given.
*As determined by flow cytometry using the rat mAbs 3.155 (anti-CD8) and GK1.5 (anti-CD4) (18) and fluorescein-conjugated anti-rat K-chain
mAb MAR18.5 (Becton Dickinson) on an Ortho system 50 H cytofluorograph with a 5-W argon laser.
tDetermined by staining with anti-Thy-1 antibody T24/31.7 (a gift of R. Hyman, Salk Institute, La Jolla, CA) using propidium iodide to exclude
dead cells (R. J. Hill and E.V.R., unpublished results). CD4 and CD8 antigens modulate after stimulation.
*Determined by in situ hybridization analysis from 4-month exposures.
§Determined by quantitative RNase probe protection analysis. Quantitation is done by using a 32P-labeled cRNA transcript (12) identical to that
used for in situ hybridization, which exhibits a lower background than seen in Fig. 1. Values given were derived from two or more independent
RNA preparations as indicated.
Values in column E divided by those in column D.
IIUnits of IL-2 per ml produced in 24 hr by 106 cells per ml of culture.
**Two previously reported in situ hybridization experiments yielded 17% and 24% of total spleen positive for IL-2 mRNA at 4 weeks exposure
(12), which included all cells with 21 grain above background.
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The levels of IL-2 RNA accumulated by the eliminated
populations similarly account for 85% of the IL-2 RNA
expressed in the unfractionated spleen cells. Therefore,
complement treatment does not appear to interfere with the
ability of the surviving cells to express the IL-2 gene.
Quantitative RNase protection analysis (Fig. 1 A and B)
demonstrated that strikingly similar amounts of IL-2 RNA
could be induced in eliminated splenocyte populations,
whether the cells depleted were CD8+ or CD4+ (compare 4-
and 8- in lanes marked A23187 + PMA). Table 1 (column E)
shows that populations from which all CD4+ cells had been
removed accumulated only three times less IL-2 RNA than
populations from which only CD8 + cells were removed. As
we have previously noted (12), removal of CD4 + and CD8 +
cells resulted in >95% loss of inducible IL-2RNA expression
under these conditions. Assuming that B cells and nonlym-
phoid cells survive equally in both eliminated populations,
this implies that a significant fraction of the IL-2 RNA
inducible in total spleen is present in CD8 + cells. Indeed,
both induced populations included significant fractions of
cells with IL-2 transcripts detectable by in situ hybridization
(Table 1, column D). In at least five experiments with
eliminated or unfractionated populations, we have noted that
CD8 + cells are slightly enriched and CD4+ cells are slightly
depleted following stimulation (Table 1, column C, and
unpublished results). Hence, the 12.6% positive cells in the
CD8- population presumably reflect responses from among
the 13-15% CD4+ cells remaining, and the 6.8% positive
cells in the CD4- population were drawn from the 10-13%
CD8+ cells (Table 1, compare columns C and D). This
suggests that at least 80o of CD4+ cells and about 50% of
CD8+ cells can express IL-2 RNA, as discussed further
below.
A
Con A
PMA
-+ E T 4 8
B
A23187
PMA
T 4 8
The accumulation of IL-2 RNA in response to A23187 and
PMA was similar in individual CD4' and CD8' cells. As
demonstrated by the representative in situ hybridization
analysis shown in Fig. 2, the grain distributions for IL-2
producers within the CD4- and CD8 - depleted populations
were hardly distinguishable, except in the overall percentage
of cells involved. This result agrees with calculations from
the quantitative RNase protection analysis, which implied
that CD8+ IL-2 producers accumulate high levels of IL-2
RNA (-500 molecules per cell), although somewhat lower,
on average, than individual CD4+ IL-2 producers (=800
molecules per cell; Table 1, column F). As shown in column
G of Table 1, IL-2 protein was secreted by all populations in
relative amounts consistent with the amount of IL-2 RNA
present at 24 hr (compare columns D and F). RNase mapping
of the IL-2 RNA accumulated by these cells demonstrated
that all three populations use identical 5' start and 3' poly(A)
sites (Fig. 1 and data not shown), further indicating that the
IL-2 RNA present is in the form of the mature, functional
message. Taken together, these measurements indicate that
about half of the surviving CD8+ T-cell population can
respond to A23187 and PMA by accumulation of bona fide
IL-2 mRNA to levels comparable to those in CD4+ cells.
To test further whether such a high fraction of CD8+ cells
is inducible, we have used two other sets of results to
calculate the expected frequencies of potential IL-2 produc-
ers, x and y, in the CD8+ and CD4+ populations, respec-
tively. One set of results is that for total spleen (Table 1) in
which about 23% of surviving cells after stimulation were T
cells. The relative survival rates of CD4+ and CD8+ cells
(column C) imply that 10% were CD8+ and 13% were CD4+.
The second set of results is from the analysis of enriched T
cells described above, in which 42% of input cells were CD4+
CAnti-CD3 A23187
t PMA t PMA
T 8 4 T 8 4
Con A
- PMA
- 4 8
to - *- Probe - -- Probe
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FIG. 1. Quantitation and mapping of 5' ends of IL-2 mRNA accumulated by splenic T cells in response to various stimuli. (A) RNase
protection of an Acc I-HincII cRNA probe spanning the IL-2 cap site, using cytoplasmic RNA isolated after 24 hr in culture with A23187 or
Con A and PMA. The migration of the fragment protected by RNA with the reported IL-2 cap site is marked as 101 nt. - or +, Probe incubated
with 20,g of yeast tRNA and carried through the analysis as described below without (-) or with (+) RNase A and T1 treatment, respectively.
E, 20 jg of RNA isolated from the thymic lymphoma EL4.E1, stimulated for 4 hr with 10 ng of PMA per ml, as a positive control. T, Total
spleen; 4-, CD4- spleen; 8-, CD8 - spleen. For all samples stimulated with A23187, 5 x 106 cell equivalents (16-21 ug of RNA) were used,
and for the total, CD4-, and CD8- Con A-stimulated samples, 107, 1.3 x 107, and 9 x 106 cell equivalents (20-28 .ug of RNA) were used,
respectively. The exposure time shown was 2 days. IL-2 RNA levels in these Con A-stimulated samples were measured to be 6 molecules per
cell for total spleen, 2 molecules per cell for CD8- spleen, and 0.2 molecule per cell for CD4- spleen. (B) Total, CD4-, and CD8- splenocytes
were stimulated for 24 hr with PMA and either A23187 or a 1:10 dilution of anti-CD3 hybridoma supernatant, and 1 x 10' cell equivalents of
cytoplasmic RNA from each was used to protect the IL-2 probe. The exposure time was 20 hr. In these samples, the 5' probe was used for
quantitation. The levels of IL-2 RNA per cell were calculated to be 207, 173, and 206 molecules per cell for the total, CD8-, and CD4- cells
stimulated with A23187 and PMA, respectively, and 26, 23, and 1 molecule per cell for total, CD8-, and CD4- cells stimulated with anti-CD3
and PMA, respectively. (C) RNase protection as inA, using 2 x 107cell equivalents (30-44u g) ofcytoplasmic RNA isolated from cells stimulated
for 6 hr. This film was exposed for 6 days. The levels of IL-2 RNA quantitated in these samples were 10 molecules per cell for total spleen,
5 molecules per cell for CD8- spleen, and 3 molecules per cell for CD4- spleen.
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FIG. 2. Distribution of IL-2 mRNA accumulated in different
classes of splenic IL-2 producers in response to A23187 and PMA.
Total, CD4-eliminated, and CD8-eliminated spleen cells were cul-
tured with or without inducers and probed for IL-2 RNA by in situ
hybridization. The histograms plot the corrected percentages of cells
in induced populations [ni(corr)] that exhibited the indicated numbers
of grains in a representative experiment. Higher grain numbers are
associated with higher numbers of transcripts per cell (12). The grain
counts for each population, induced and uninduced, were determined
from a 4-week exposure (29 days) of a representative experiment,
and the corrected histograms were derived by subtracting back-
ground values. The similarity between the distributions of IL-2 RNA
among producing cells in all three populations was observed in three
experiments.
and 27% were CD8 +. Here, about 90%o ofthe input cells were
viable 24 hr after stimulation, suggesting only minor popu-
lation changes. At most, if all dying cells were CD4+, the
stimulated cells were 35% CD4+ and 30% CD8 . These
values can be used to solve for x and y with two independent
equations. (i) The fraction of cells positive by in situ hybrid-
ization is
Fraction inducible = (CD4+ poststimulation)y
+ (CD8+ poststimulation)x. [1]
(ii) As shown in Table 1, column E, CD4-eliminated spleen
cells make one-third as much IL-2 RNA as CD8-eliminated
spleen cells (i.e., 33 ± 3 vs. 100 ± 28). Then, if an average
CD8 + responder has 500 copies of IL-2 RNA and an average
CD4+ responder has 800 copies, it follows that (CD8+
poststimulation)(500x) = 1/3(CD4+ poststimulation)(800y),
or
(CD8+ poststimulation)x =
8/15 (CD4+ poststimulation)y. [2]
In the total spleen analysis, the average fraction inducible
is 0.2 (Table 1, column D). By using our estimates for CD4+
and CD8 + subsets after stimulation, y 1.0 and x = 0.7, with
almost all CD4+ cells and over half of CD8+ cells respond-
ing. Similarly, in the experiment with enriched T cells, 0.47
of the cells could express IL-2 RNA. Depending upon
whether CD4+ cells are assumed to have died preferentially,
values for y range from 0.73 to 0.9 and those for x range from
0.54 to 0.61. These are in good agreement with the previous
values and those estimated from CD4- or CD8-eliminated
populations (Table 1). Altogether, these calculations indicate
the consistency of the in situ hybridization analyses and
support the competence of at least half of splenic CD8 + cells
to make IL-2.
To test whether the mode of triggering influenced respon-
siveness, we replaced A23187 with either of two polyclonal
stimuli that could mimic more physiologic triggering by
binding to the T-cell receptor-i.e., the lectin ConA or amAb
against the e subunit of CD3. In all cases, PMA was added to
obviate the requirement for accessory cells. RNase probe
protection analysis demonstrated that 24 hr of culture with 6
kug of Con A per ml stimulated spleen cells to express IL-2
mRNA, although at lower levels (by a factor of =10-20) than
in cultures induced with A23187 (Fig. 1 legend). Consistent
with the levels of RNA detected, Con A-stimulated cultures
also secrete, on average, fewer units of IL-2 activity per ml
(by a factor of 10-30) than A23187-stimulated cultures (data
not shown). However, the effects of Con A on CD4+ and
CD8+ cells were not the same. As shown in Fig. lA, probe
protection analysis revealed that CD4- splenocytes ex-
pressed only about 1/10th as much IL-2 mRNA as CD8-
cells after 24 hr of stimulation with Con A and PMA. They
correspondingly secreted lower titers of IL-2 (by a factor of
8-10) than CD8- splenocytes during the incubation (not
shown). The poor IL-2 response of CD8 + cells did not result
from an overall inability to respond to Con A and PMA, for
CD8+ cells were fully activated to express IL-2 receptors
(J.A.Y., data not shown). As shown in Fig. 1B, CD8' cells
also expressed less IL-2 mRNA (by a factor of at least 10)
than CD4+ cells when stimulated for 24 hr with anti-CD3 and
PMA. Thus, although many or most CD8+ cells can accu-
mulate IL-2 mRNA similarly to CD4 + cells when stimulated
with a calcium ionophore, they do not appear to do so when
stimulated by Con A or by anti-CD3.
The differences in overall accumulation of IL-2 protein are
consistent with a prolonged disparity between the levels of
translatable IL-2 mRNA in CD4+ and CD8 + cells, but they
do not rule out a brief response in the CD8 + cells. This was
of concern because time course analysis of IL-2 RNA
accumulation in total spleen revealed that the kinetics of the
accumulation were different in response to Con A and PMA
than for A23187 and PMA (Fig. 3). In response to Con A, an
initial peak was seen at 6 hr of stimulation, then a decline and
a second peak at 24 hr, instead of the continued increase
through 24 hr of stimulation induced by A23187. This is
consistent with previous reports of a peak in IL-2 mRNA
expression =5 hr after induction with mitogen (9, 10, 19). To
analyze the initial activation process, we compared the levels
of IL-2 mRNA in splenic subpopulations after only 6 hr of
stimulation with Con A (Fig. 1C). In three experiments with
either Con A or anti-CD3 stimulation, we found that CD8+
cells contribute at least half as much accumulated IL-2
mRNA as CD4 + cells at this time point. This result suggests
ConA + PMA A23187 + PMA
- 6 12 18 24 30 - 6 12 18 24 30
FIG. 3. Time course of IL-2 mRNA production by total spleen
cells in response to different stimuli. Cell cultures consisting of 4 x
10' cells supplemented with Con A and PMA and 2 x 107 cells
supplemented with A23187 and PMA were incubated for the indi-
cated times (given in hours). One-half of the resulting cytoplasmic
RNA isolated from each culture was blotted in descending 2-fold
serial dilutions as described (12). Viable cell equivalents ranged from
13 to 20 x 106 cells for Con A and 6.5 to 10 x 106 cells for A23187,
with the lowest numbers of viable cells in the 6-hr Con A and 24-hr
A23187 cultures and the highest numbers in the uninduced controls.
The autoradiograph shown is an overnight exposure of the filter
hybridized with an IL-2 cDNA probe.
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that CD8 + T cells may initially activate the IL-2 gene when
stimulated by means of the T-cell receptor for antigen, but
that under these conditions, CD8 + and CD4 + cells differen-
tially regulate subsequent IL-2 mRNA accumulation.
DISCUSSION
We have used in situ hybridization to measure the compe-
tence of individual splenocytes to express the IL-2 gene prior
to any antigen-driven clonal expansion. This approach has
revealed a strikingly broad phenotypic distribution of cells
with intrinsic competence to make IL-2, for many or most
CD8 + cells as well as CD4 + cells are fully competent under
certain stimulation conditions. A difference between CD4'
and CD8+ IL-2 producers emerged, however, in their re-
sponses to different polyclonal activators. Though the cal-
cium ionophore induced sustained IL-2RNA accumulation in
both, the membrane receptor ligands Con A and anti-CD3
provoked a limited IL-2 production response in the CD8+
cells as compared to the CD4' cells. Thus, many CD8'
splenocytes appear to differ from CD4+ cells not so much in
their potential to express the IL-2 gene as in their interpre-
tations of particular activation stimuli.
Previous work (9-11, 20, 21), using bulk culture and limiting
dilution analysis, has established that some CD8+ cells have the
ability to secrete IL-2, but it did not reveal the prevalence of
potential IL-2 producers in the CD8+ population that we
observe upon stimulation with calcium ionophore and PMA.
Several methodological differences may explain our findings.
We have looked within the first 24 hr of stimulation, which may
be important for detecting IL-2 production by CD8 + cells (cf.
refs. 20 and 21). In particular, in situ hybridization analysis
allows us to look at the primary T-cell response prior to clonal
expansion. Recent studies using the Pgp-1 marker to identify
memory cells (22) support the interpretation that most (70%) of
our splenic CD8 + cells are indeed virgin T cells. By contrast,
A23187 and PMA do not induce IL-2 RNA in many long-term
killer cell lines (T. J. Novak and E.V.R., unpublished data),
suggesting either that CD8 + cells may lose this capacity after
exposure to antigen (20, 21), or that those that proliferate
extensively in vitro come primarily from the noninducible
fraction. In any case, the inducibility of IL-2 in about half ofthe
CD8+ cells after stimulation with calcium ionophore and
phorbol ester clearly shows that in virgin CD8 + cells the IL-2
gene need not be locked in an inactive chromatin configuration.
The gene itself may always be competent to be expressed in
mature primary T cells.
Although there appears to be little difference between
CD4 + and CD8 + cells in the potential inducibility of their
IL-2 genes by A23187 and PMA, there is a clear difference in
their abilities to accumulate IL-2 mRNA following prolonged
stimulation with PMA and either Con A or mAb directed
against CD3. Similarly, in response to antigen, IL-2 produc-
tion is apparently limited to certain responding T cells
dominated by, though not restricted to, cells of the CD4+
phenotype (4-6). Our results from the 6-hr stimulation with
T-cell receptor ligands, as well as previous reports in the
literature (9, 10), support the hypothesis that transcription
may initially be comparable in the two cell types but that
RNA accumulation is limited at a later step in CD8+ cells.
Such a mechanism might affect the accumulation of IL-2
transcripts in individual cells or decrease the frequency of
responding cells. Several laboratories have reported that
cycloheximide, which blocks protein elongation, enhances
the lectin-induced accumulation of IL-2 mRNA (9, 10, 23)
without affecting the transcriptional activity of the gene (24).
These data suggest that a protein product may be responsible
for limiting IL-2 mRNA accumulation after stimulation with
lectin. CD4+ and CD8+ T cells might differentially express
this regulatory protein product, with its expression being
particularly prominent in CD8+ lymphocytes. The accumu-
lation of high levels of IL-2 mRNA in both subpopulations of
mature T cells and the kinetics of that response suggest that
ionophore and phorbol ester may bypass this proposed
regulatory mechanism altogether. Further work is required to
test this possibility directly. However, the results presented
here persuasively suggest that the difference between cells
committed to "IL-2-producing" and "non-IL-2-producing"
lineages may not be attributed either to the chromatin
structure of the IL-2 gene or to the initial availability of
specific transcription factors for IL-2. Particularly in these
primary T-cell populations, signal transduction and/or RNA
stabilization mechanisms may play a vital role in regulating a
surprisingly plastic set of functional responses.
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